Cns Pharmaceuticals, Inc. · NASDAQ:CNSP
Cns Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 10 institutions reported holding Cns Pharmaceuticals, Inc., 19.2% of its shares. Largest: Ikarian Capital, LLC, ADAR1 Capital Management, LLC and Stonepine Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cns Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Ikarian Capital, LLC | 136K | 9.3% | +90,000 | Aug 14, 2026 |
| ADAR1 Capital Management, LLC | 70,000 | 4.8% | new | Aug 14, 2026 |
| Stonepine Capital Management, LLC | 41,573 | 2.8% | −19,427 | Aug 17, 2026 |
| Vanguard | 17,219 | 1.2% | new | Aug 13, 2026 |
| Boothbay Fund Management, LLC | 13,524 | 0.93% | no change | Aug 14, 2026 |
| UBS | 1,461 | 0.10% | +732 | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 799 | 0.05% | −511 | Aug 11, 2026 |
| Barclays | 19 | <0.01% | new | Aug 14, 2026 |
| Barrett & Company, Inc. | 8 | <0.01% | no change | Jul 24, 2026 |
| Danske Bank A/S | 1 | <0.01% | no change | Aug 10, 2026 |